|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collisson EA, Bailey P, Chang DK and
Biankin AV: Molecular subtypes of pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 16:207–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amrutkar M and Gladhaug IP: Pancreatic
cancer chemoresistance to gemcitabine. Cancers (Basel). 9:1572017.
View Article : Google Scholar
|
|
7
|
Nakano Y, Tanno S, Koizumi K, Nishikawa T,
Nakamura K, Minoguchi M, Izawa T, Mizukami Y, Okumura T and Kohgo
Y: Gemcitabine chemoresistance and molecular markers associated
with gemcitabine transport and metabolism in human pancreatic
cancer cells. Br J Cancer. 96:457–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strobel O, Neoptolemos J, Jaeger D and
Buechler MW: Optimizing the outcomes of pancreatic cancer surgery.
Nat Rev Clin Oncol. 16:11–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: In vitro assays and techniques utilized in anticancer drug
discovery. J Appl Toxicol. 39:38–71. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi HS, Kim JH, Kim SL, Deng HY, Lee D,
Kim CS, Yun BS and Lee DS: Catechol derived from aronia juice
through lactic acid bacteria fermentation inhibits breast cancer
stem cell formation via modulation Stat3/IL-6 signaling pathway.
Mol Carcinog. 57:1467–1479. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim DY, Shin SH, Lee MH, Malakhova M,
Kurinov I, Wu Q, Xu J, Jiang Y, Dong Z, Liu K, et al: A natural
small molecule, catechol, induces c-Myc degradation by directly
targeting ERK2 in lung cancer. Oncotarget. 7:35001–35014. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tran TA, Ho MT, Song YW, Cho M and Cho SK:
Camphor induces proliferative and anti-senescence activities in
human primary dermal fibroblasts and inhibits UV-induced wrinkle
formation in mouse skin. Phytother Res. 12:1917–1925. 2015.
View Article : Google Scholar
|
|
14
|
Wang T, Luo R, Li W, Yan H, Xie S, Xiao W,
Wang Y, Chen B, Bai P and Xing J: Dihydroartemisinin suppresses
bladder cancer cell invasion and migration by regulating KDM3A and
p21. J Cancer. 11:11152020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tadros S, Shukla SK, King RJ, Gunda V,
Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, et al:
De novo lipid synthesis facilitates gemcitabine resistance through
endoplasmic reticulum stress in pancreatic cancer. Cancer Res.
77:5503–5517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al Zaid Siddiquee K and Turkson J: STAT3
as a target for inducing apoptosis in solid and hematological
tumors. Cell Res. 18:254–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao B, Lei QY and Guan KL: The Hippo-YAP
pathway: New connections between regulation of organ size and
cancer. Curr Opin Cell Biol. 20:638–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mo JS, Yu FX, Gong R, Brown JH and Guan
KL: Regulation of the Hippo-YAP pathway by protease-activated
receptors (PARs). Genes Dev. 26:2138–2143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mo JS, Meng Z, Kim YC, Park HW, Hansen CG,
Kim S, Lim DS and Guan KL: Cellular energy stress induces
AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell
Biol. 17:500–510. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu PC, Gopinath RK, Hsueh YA and Shieh
SY: CHK2-mediated regulation of PARP1 in oxidative DNA damage
response. Oncogene. 38:1166–1182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adeberg S, Bernhardt D, Harrabi SB,
Nicolay NH, Hörner-Rieber J, König L, Repka M, Mohr A, Abdollahi A,
Weber KJ, et al: Metformin enhanced in vitro radiosensitivity
associates with G2/M cell cycle arrest and elevated
adenosine-5′-monophosphate-activated protein kinase levels in
glioblastoma. Radiol Oncol. 51:431–437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferlay J, Partensky C and Bray F: More
deaths from pancreatic cancer than breast cancer in the EU by 2017.
Acta Oncol. 55:1158–1160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Infante JR, Somer BG, Park JO, Li CP,
Scheulen ME, Kasubhai SM, Oh DY, Liu Y, Redhu S, Steplewski K and
Le N: A randomised, double-blind, placebo-controlled trial of
trametinib, an oral MEK inhibitor, in combination with gemcitabine
for patients with untreated metastatic adenocarcinoma of the
pancreas. Eur J Cancer. 50:2072–2081. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Le Chevalier T, Scagliotti G, Natale R,
Danson S, Rosell R, Stahel R, Thomas P, Rudd RM, Vansteenkiste J,
Thatcher N, et al: Efficacy of gemcitabine plus platinum
chemotherapy compared with other platinum containing regimens in
advanced non-small-cell lung cancer: A meta-analysis of survival
outcomes. Lung Cancer. 47:69–80. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cassileth BR and Deng G: Complementary and
alternative therapies for cancer. Oncologist. 9:80–89. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davis FM, Stewart TA, Thompson EW and
Monteith GR: Targeting EMT in cancer: Opportunities for
pharmacological intervention. Trends Pharmacol Sci. 35:479–488.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeRan M, Yang J, Shen CH, Peters EC,
Fitamant J, Chan P, Hsieh M, Zhu S, Asara JM, Zheng B, et al:
Energy stress regulates hippo-YAP signaling involving AMPK-mediated
regulation of angiomotin-like 1 protein. Cell Rep. 9:495–503. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Y, Shi Q, Xu S, Du C, Liang L, Wu K,
Wang K, Wang X, Chang LS, He D and Guo P: Curcumin promotes KLF5
proteasome degradation through downregulating YAP/TAZ in bladder
cancer cells. Int J Mol Sci. 15:15173–15187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim YN, Choe SR, Cho KH, Kang J, Park CG
and Lee HY: Resveratrol suppresses breast cancer cell invasion by
inactivating a RhoA/YAP signaling axis. Exp Mol Med. 49:e296. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malik A, Sultana M, Qazi A, Qazi MH,
Parveen G, Waquar S, Ashraf AB and Rasool M: Role of natural
radiosensitizers and cancer cell radioresistance: An update. Anal
Cell Pathol (Amst). 2016:61465952016.PubMed/NCBI
|
|
33
|
Chen L, Gilkes DM, Pan Y, Lane WS and Chen
J: ATM and Chk2-dependent phosphorylation of MDMX contribute to p53
activation after DNA damage. EMBO J. 24:3411–3422. 2005. View Article : Google Scholar : PubMed/NCBI
|
